A comparative analysis of fetal mirror-image dextrocardia in China pre- and post-COVID-19 lockdown lifting.

Publication date: Jun 22, 2026

To analyze the epidemiological characteristics and incidence of mirror-image dextrocardia in pregnant women and fetuses before and after the lifting of coronavirus disease (COVID-19) control measures in China on December 7, 2022. We retrospectively collected data on the number of pregnant women who underwent prenatal ultrasound examinations and incidence of mirror-image dextrocardia in fetuses at three hospitals in Xi’an during three time periods: before the COVID-19 pandemic (January to April 2019), during the COVID-19 control measures (January to April 2022), and after the lifting of COVID-19 restrictions (January to April 2023). We then conducted an online epidemiological survey among pregnant women across China and collected the names of pregnant women with fetal mirror dextrocardia, as well as the following clinical information: age, location (province and city), gestational week at which mirror-image dextrocardia was detected, last menstrual period date, date of first pregnancy diagnosis, obstetric history, conception method, estimated due date, ultrasound diagnosis result, and genetic testing result. COVID-19-related information was also recorded. Between January and April 2019 (pre-pandemic), 9,112 pregnant women underwent prenatal ultrasound examinations at 3 hospitals in Xi’an. Between January and April 2022 (COVID-19 control measures period), 11,071 pregnant women underwent prenatal ultrasound examinations, and 1 case of fetus with mirror-image dextrocardia was identified (incidence rate, 0. 9/10,000). Between January and April 2023 (after the lifting of COVID-19 restrictions), 11,516 pregnant women underwent prenatal ultrasound examinations, and 21 fetuses with mirror-image dextrocardia were detected, with an alarming incidence rate of 18. 2/10,000. After the lifting of COVID-19 restrictions, the incidence of mirror-image dextrocardia in fetuses in Xi’an showed a significant increase (8-20-fold higher) compared to that observed in both the pre-pandemic and strictly controlled pandemic periods. An online investigation showed that 111 cases of fetal mirror-image dextrocardia were detected in 22 other provinces of China after the lifting of COVID-19 restrictions. All pregnant women with fetal mirror-image dextrocardia had a history of SARS-CoV-2 infection after the lifting of COVID-19 restrictions, which coincided with the early stages of embryo development, approximately 4-6 weeks after their last menstrual period. Our data showed that the increase in cases of fetal situs solitus with dextrocardia coincided temporally with the outbreak of COVID-19 in China. This temporal overlap may suggest a potential association between the two events.

Open Access PDF

Concepts Keywords
Childbirth COVID-19
China Epidemiology
Coronavirus Incidence rate
Mirror-image dextrocardia
Pandemic

Semantics

Type Source Name
disease MESH image
disease MESH dextrocardia
disease MESH COVID-19
pathway KEGG Coronavirus disease
pathway REACTOME SARS-CoV-2 Infection
disease MESH Long Covid
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Coenzyme M
disease MESH severe acute respiratory syndrome
disease MESH strains
disease MESH infections
disease MESH preterm birth
disease MESH fetal distress
disease MESH genetic diseases
disease MESH fever
disease MESH sore throat
disease MESH diarrhea
disease MESH aches
disease MESH IBM
disease MESH congenital heart defects
disease MESH ventricular septal defect 3
disease MESH atrial septal defect 1
disease MESH left atrial isomerism
disease MESH aberrant left subclavian artery
disease MESH persistent truncus arteriosus
disease MESH triploid
disease MESH primary ciliary dyskinesia
disease MESH situs inversus
disease MESH CILD7
disease MESH atrioventricular septal defect
disease MESH anxiety
disease MESH patent foramen ovale
disease MESH levocardia
disease MESH bends
disease MESH PCD
disease MESH cough
disease MESH pulmonary fibrosis
disease MESH respiratory failure
pathway REACTOME Immune System
disease MESH injury
disease MESH stillbirths
disease MESH congenital abnormalities
disease MESH atrial septal defects
disease MESH patent ductus arteriosus
disease MESH heart diseases
disease MESH plan
disease MESH Pneumonia
disease MESH persistent left superior vena cava
disease MESH atrioventricular nodal reentrant tachycardia
drug DRUGBANK Calcium
drug DRUGBANK Guanosine
drug DRUGBANK Serine
disease MESH Dis
disease MESH chest injury
disease MESH ST Elevation Myocardial Infarction

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *